With the growing availability of patient-derived samples, cell lines, genomic datasets, and emerging single-cell studies, researchers are now beginning to systematically dissect the genetic, epigenetic, and transcriptional programs underlying lineage plasticity and resistance evolution in EGFR-mutant NSCLC. Here, EGFR is linked to non-small cell lung carcinoma.